SCHEMBL5527635

SCHEMBL5527635

C[Si](C)(C)OC(c1cccc2ccccc12)(c1cccc2ccccc12)[C@@H]1CCCN1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
SSTR4 P31391 2/20 0.34
HTR6 P50406 1/20 0.34
ADORA2A P29274 5/20 0.33
ADORA1 P30542 5/20 0.33
KCNH2 Q12809 4/20 0.33
CYP3A4 P08684 3/20 0.33
ADORA3 P0DMS8 2/20 0.33
ADORA2B P29275 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
NR1I2 O75469 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5527642 1.00 CYP2D6 (0.40) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL14326145 0.85 CYP2D6 (0.39) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL10326338 0.83 KDM4E (0.42) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL13363845 0.82 CYP2D6 (0.37) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL10326853 0.80 KDM4E (0.43) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL12996878 0.80 KDM4E (0.43) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL10326344 0.80 KDM4E (0.43) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL1447193 0.78 CYP2D6 (0.56) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL2574515 0.78 CYP2D6 (0.56) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL3004482 0.78 CYP2D6 (0.56) CYP2D6KDM4ECYP1A2CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276142-A1 Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds CHEMINOVA A/S (DK) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276142-A1 Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds CBR1, CBR3, HAO1 CYP2D6 534/4885KDM4E 3878/4885CYP1A2 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.